Division of Diabetes and Endocrinology, Scripps Clinic Medical Group, 12395 El Camino Real, Suite 317, San Diego, CA 92130, USA.
Division of Diabetes and Endocrinology, Scripps Clinic Medical Group, 12395 El Camino Real, Suite 317, San Diego, CA 92130, USA.
Endocrinol Metab Clin North Am. 2020 Jun;49(2):303-314. doi: 10.1016/j.ecl.2020.02.007.
There are many valid reasons why health care providers are reluctant to use pharmacotherapy for weight management: the negative track record of weight loss medications has led to numerous safety concerns, and there is lack of formal training in obesity medicine and a general discomfort with using these medications. New medications have improved safety profiles, and their mechanisms are based on recent discoveries of how humans regulate weight. This, combined with a change in American health coverage, has slowly increased the use weight loss medication. This article examines the barriers and changes that are increasing the use of anti-obesity medications.
减肥药物的不良记录导致了许多安全问题，而且肥胖医学方面的正规培训不足，以及普遍对使用这些药物感到不适。新型药物的安全性有了改善，其作用机制基于人类如何调节体重的最新发现。再加上美国医保覆盖范围的变化，这慢慢增加了减肥药物的使用。本文探讨了增加抗肥胖药物使用的障碍和变化。
